Innovation in Healthcare & Rapid Diagnostics and the Impact on Sepsis

Sessions Descriptions: 

Innovation in Healthcare

Serial Entrepreneur and Billionaire, Mark Cuban, shares his thoughts on Innovation in Healthcare and how he is investing to create disruption in the industry.

Rapid Diagnostics and the Impact on Sepsis

This talk includes a patient’s journey — as a heart transplant recipient and sepsis survivor — and the potential for rapid diagnostics to change the treatment paradigm for patients at risk of sepsis. 

These sessions were originally presented in September 2021 as part of the 2021 Sepsis Alliance Summit.

Target Audience

Nurses, Advanced Practice Providers, Physicians, Emergency Responders, Pharmacists, Medical Technologists, Respiratory Therapists, Physical/ Occupational Therapist, Social Workers, Mental Health Professionals, Students, IT Professionals, Sepsis Survivors, Advocates, and more! 

Course summary
Course opens: 
Course expires: 

Innovation in Healthcare

Mark Cuban

Owner, Dallas Mavericks NBA

An entrepreneur at heart, at a young age Mark Cuban began selling stamps door-to-door and gave disco lessons to help pay his way through Indiana University. Cuban was inspired to strike out on his own when he was fired from a software shop for closing a $15,000 sale instead of cleaning up the store. In 1995, Cuban founded video portal with fellow Indiana University alum, Todd Wagner. Four years later, he sold to Yahoo for $5.7 billion. Today he owns the NBA's Dallas Mavericks and has stakes in Magnolia Pictures, AXS TV, and dozens of small startups. Cuban invests in mission-driven companies such as Luminaid, which provides lighting to disaster areas, and Mahmee, a maternal healthcare tech company. He is also well known as being an investor on the Emmy award winning show, Shark Tank.  

Midori Lawler

Board of Directors, Sepsis Alliance

Microsoft for Startups Senior Audience Evangelism Manager, Microsoft

Midori Lawler’s passion is working with startups and giving back. She joined Microsoft in 2005 and has been working with tech startups for the past 15 years. She launched the Microsoft BizSpark program in 2008 which was the first startup program in the company’s history. In typical startup fashion, she has worn many hats, but her specialty is Marketing Communications and Events.  She was initially responsible for driving awareness of the BizSpark brand and adoption of Microsoft technologies but over the years has expanded her expertise to include Program Operations, Field Enablement, Partner Programs, Data & Analytics and Content Strategy. Midori currently manages the teams that provide Program Support and Technical Enablement for startups in the Microsoft for Startups program. She is a startup ambassador, always seeking to find ways to help startups.  

In 2014, Midori was one of seven employees chosen to be a Microsoft Loaned Professional and run the annual Microsoft Giving Campaign. Her team was responsible for engaging all US employees, providing education and training, connecting employees to volunteer opportunities that align to their skills and interests and continuing to nurture the culture of giving. The team raised over $113M for nonprofits and schools.  

Midori has a strong personal interest in increasing sepsis awareness. Although she has not had sepsis herself, in the past 4 years, several people she loves have had sepsis, including her mom, best friend, cousin and family friend. She has personally witnessed how life threatening this illness can be and how difficult it is to live with the consequences of sepsis, including loss of limbs. 

Earlier in her career, Midori worked in Technology Marketing for several hi-tech startups, as well as established corporations such as Dell Computer, Motorola, and IBM. She has a bachelor’s degree and an MBA from Pepperdine University. Midori has two sons and is based in Seattle, Washington. 

Rapid Diagnostics and the Impact on Sepsis

John J. Sperzel

Chairman & CEO, T2 Biosystems

John Sperzel is Chairman, Chief Executive Officer, and member of the Board of Directors at T2 Biosystems (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing pathogens. He has spent more than three decades advancing diagnostic technologies, having served as President, Chief Executive Officer and member of the Board of Directors for a number of public and private diagnostic companies. John earned a Bachelor of Science in Business/Management from Plymouth State University and serves on the Board of Directors for Ontera, Inc. After surviving an acute, life-threatening illness that resulted in a heart transplant, and a multidrug-resistant bacterial infection that led to sepsis, John wrote a best-selling book and continues to pursue his passion of advancing life-saving technologies. 

Thomas Heymann

President & CEO, Sepsis Alliance

Tom has been part of Sepsis Alliance since 2007, serving as President and CEO since 2013. Tom has led Sepsis Alliance to consecutive years of growth including the organization’s drive to increase sepsis awareness from 19% to 71% and the expansion of to a site serving more than 2.5 million patients, family members, caregivers and medical professionals each year. Tom also led the organization’s efforts to launch the Sepsis Alliance Clinical Community and the Sepsis Alliance Institute which have trained more than 40,000 health professionals, and Sepsis Alliance Voices, a new platform for national and state advocacy. Tom has senior business development and operating experience in the commercial and not for profit sectors. He served as Chief Operating Officer at Little Kids Rock, the country’s largest free instrumental music charity, and as Executive Director at Young Audiences New York. He currently serves as an advisory board member of the Canadian Sepsis Foundation. 


No continuing education credits are offered for these sessions.

Medical Disclaimer

The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare provider. Sepsis Alliance recommends users consult their physician or healthcare provider regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.

Please login or register to take this course.


This activity includes the following for each session:

  • Pre-recorded presentation